Literature DB >> 6182404

PGI2 prevents ischemia-induced alterations in cardiac catecholamines without influencing nerve-stimulation-induced catecholamine release in nonischemic conditions.

K Schrör, H Darius, K Addicks, R Köster, E F Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6182404     DOI： 10.1097/00005344-198209000-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN： 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  5 in total

1.  Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig.

Authors:  W J van der Giessen; B Schoutsen; J G Tijssen; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

2.  Prostacyclin and iloprost: equal efficiency in preserving high energy phosphates in the dog heart following coronary artery ligation.

Authors:  M Pissarek; H Goos; J Nöhring; J Graff; G Buller; I Beyerdörfer; H J Mest; K F Lindenau; E G Krause
Journal:  Basic Res Cardiol       Date:  1987 Nov-Dec       Impact factor: 17.165

Review 3.  Significance of myocardial eicosanoid production.

Authors:  M van Bilsen; W Engels; G J van der Vusse; R S Reneman
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

4.  Effects of prostacyclin analogue, OP-2507, on function and metabolism in the ischemic working rat heart.

Authors:  T Oguchi; S Kashimoto; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

5.  Protective effects of prostaglandin I2 analogues on CPK release in rat's heart-lung preparation.

Authors:  S Kashimoto; T Nakamura; T Oguchi; M Kume; T Kumazawa
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.